These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33369061)

  • 1. Further delineation of a recognizable type of syndromic short stature caused by biallelic SEMA3A loss-of-function variants.
    Gileta AF; Helgeson ML; Leonard JMM; Pyle LC; Subramanian HP; Arndt K; Hawkes CP; Del Gaudio D
    Am J Med Genet A; 2021 Mar; 185(3):889-893. PubMed ID: 33369061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biallelic SEMA3A defects cause a novel type of syndromic short stature.
    Hofmann K; Zweier M; Sticht H; Zweier C; Wittmann W; Hoyer J; Uebe S; van Haeringen A; Thiel CT; Ekici AB; Reis A; Rauch A
    Am J Med Genet A; 2013 Nov; 161A(11):2880-9. PubMed ID: 24124006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation screening of SEMA3A and SEMA7A in patients with congenital hypogonadotropic hypogonadism.
    Känsäkoski J; Fagerholm R; Laitinen EM; Vaaralahti K; Hackman P; Pitteloud N; Raivio T; Tommiska J
    Pediatr Res; 2014 May; 75(5):641-4. PubMed ID: 24522099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recognizable type of syndromic short stature with arthrogryposis caused by bi-allelic SEMA3A loss-of-function variants.
    Baumann M; Steichen-Gersdorf E; Krabichler B; Müller T; Janecke AR
    Clin Genet; 2017 Jul; 92(1):86-90. PubMed ID: 28075028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation sequencing of patients with congenital anosmia.
    Alkelai A; Olender T; Dode C; Shushan S; Tatarskyy P; Furman-Haran E; Boyko V; Gross-Isseroff R; Halvorsen M; Greenbaum L; Milgrom R; Yamada K; Haneishi A; Blau I; Lancet D
    Eur J Hum Genet; 2017 Dec; 25(12):1377-1387. PubMed ID: 29255181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of SEMA3A variants identified in Chinese patients with isolated hypogonadotropic hypogonadism.
    Dai W; Li JD; Zhao Y; Wu J; Jiang F; Chen DN; Zheng R; Men M
    Clin Genet; 2020 May; 97(5):696-703. PubMed ID: 32060892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann Syndrome.
    Barraud S; Delemer B; Poirsier-Violle C; Bouligand J; Mérol JC; Grange F; Higel-Chaufour B; Decoudier B; Zalzali M; Dwyer AA; Acierno JS; Pitteloud N; Millar RP; Young J
    Neuroendocrinology; 2021; 111(1-2):99-114. PubMed ID: 32074614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome.
    Hanchate NK; Giacobini P; Lhuillier P; Parkash J; Espy C; Fouveaut C; Leroy C; Baron S; Campagne C; Vanacker C; Collier F; Cruaud C; Meyer V; García-Piñero A; Dewailly D; Cortet-Rudelli C; Gersak K; Metz C; Chabrier G; Pugeat M; Young J; Hardelin JP; Prevot V; Dodé C
    PLoS Genet; 2012 Aug; 8(8):e1002896. PubMed ID: 22927827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development.
    Young J; Metay C; Bouligand J; Tou B; Francou B; Maione L; Tosca L; Sarfati J; Brioude F; Esteva B; Briand-Suleau A; Brisset S; Goossens M; Tachdjian G; Guiochon-Mantel A
    Hum Reprod; 2012 May; 27(5):1460-5. PubMed ID: 22416012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sema3a plays a role in the pathogenesis of CHARGE syndrome.
    Ufartes R; Schwenty-Lara J; Freese L; Neuhofer C; Möller J; Wehner P; van Ravenswaaij-Arts CMA; Wong MTY; Schanze I; Tzschach A; Bartsch O; Borchers A; Pauli S
    Hum Mol Genet; 2018 Apr; 27(8):1343-1352. PubMed ID: 29432577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients.
    Gu WJ; Zhang Q; Wang YQ; Yang GQ; Hong TP; Zhu DL; Yang JK; Ning G; Jin N; Chen K; Zang L; Wang AP; Du J; Wang XL; Yang LJ; Ba JM; Lv ZH; Dou JT; Mu YM
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1480-9. PubMed ID: 26031747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.
    Pitteloud N; Meysing A; Quinton R; Acierno JS; Dwyer AA; Plummer L; Fliers E; Boepple P; Hayes F; Seminara S; Hughes VA; Ma J; Bouloux P; Mohammadi M; Crowley WF
    Mol Cell Endocrinol; 2006 Jul; 254-255():60-9. PubMed ID: 16764984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant variants in the splicing factor PUF60 cause a recognizable syndrome with intellectual disability, heart defects and short stature.
    El Chehadeh S; Kerstjens-Frederikse WS; Thevenon J; Kuentz P; Bruel AL; Thauvin-Robinet C; Bensignor C; Dollfus H; Laugel V; Rivière JB; Duffourd Y; Bonnet C; Robert MP; Isaiko R; Straub M; Creuzot-Garcher C; Calvas P; Chassaing N; Loeys B; Reyniers E; Vandeweyer G; Kooy F; Hančárová M; Havlovicová M; Prchalová D; Sedláček Z; Gilissen C; Pfundt R; Wassink-Ruiter JSK; Faivre L
    Eur J Hum Genet; 2016 Jan; 25(1):43-51. PubMed ID: 27804958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIN3A Defects Associated with Syndromic Congenital Hypogonadotropic Hypogonadism: An Overlap with Witteveen-Kolk Syndrome.
    Schnöll C; Krepischi ACV; Renck AC; Amato LGL; Kulikowski LD; Dantas NCB; Costa EMF; Mendonca BB; Latronico AC; Jorge AAL; Silveira LFG
    Neuroendocrinology; 2023; 113(8):834-843. PubMed ID: 36758531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism.
    Stamou MI; Georgopoulos NA
    Metabolism; 2018 Sep; 86():124-134. PubMed ID: 29108899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the genetic spectrum of ANOS1 mutations in patients with congenital hypogonadotropic hypogonadism.
    Gonçalves CI; Fonseca F; Borges T; Cunha F; Lemos MC
    Hum Reprod; 2017 Mar; 32(3):704-711. PubMed ID: 28122887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and genetic analysis of a case of Waardenburg syndrome type 2 with hypogonadotropic hypogonadism caused by
    Wang SQ; Chen Y; Luo KH; Shi NJ; Xiao KL; Cui ZH; Zeng TS; Li HQ
    Yi Chuan; 2022 Dec; 44(12):1158-1166. PubMed ID: 36927561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted next generation sequencing approach identifies eighteen new candidate genes in normosmic hypogonadotropic hypogonadism and Kallmann syndrome.
    Quaynor SD; Bosley ME; Duckworth CG; Porter KR; Kim SH; Kim HG; Chorich LP; Sullivan ME; Choi JH; Cameron RS; Layman LC
    Mol Cell Endocrinol; 2016 Dec; 437():86-96. PubMed ID: 27502037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [GnRH deficiency: new insights from genetics].
    Kottler ML; Hamel A; Malville E; Richard N
    J Soc Biol; 2004; 198(1):80-7. PubMed ID: 15146960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BDV Syndrome: An Emerging Syndrome With Profound Obesity and Neurodevelopmental Delay Resembling Prader-Willi Syndrome.
    Bosch E; Hebebrand M; Popp B; Penger T; Behring B; Cox H; Towner S; Kraus C; Wilson WG; Khan S; Krumbiegel M; Ekici AB; Uebe S; Trollmann R; Woelfle J; Reis A; Vasileiou G
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3413-3427. PubMed ID: 34383079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.